Clinical Plenary #1
Nov
12
2023
Auditorium
-
Hynes Convention Center
11:30
AM
- 12:30 PM EST
Description
Abstracts
- RIVET TRIAL: PHASE 2 RCT OF RIFAMYCIN SV MMX, A NOVEL RIFAMPIN ANALOGUE, ON GUT-BRAIN AXIS CHANGES IN CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY
- MASH RESOLUTION WITHOUT FIBROSIS WORSENING AFTER BARIATRIC SURGERY IMPROVES LONG-TERM SURVIVAL
- SERIAL ENDOSCOPIC INJECTION SCLEROTHERAPY WITH N BUTYL CYANOACRYLATE GLUE VERSUS RADIOLOGICAL INTERVENTION FOR SECONDARY PROPHYLAXIS OF GASTRIC VARICEAL HEMORRHAGE IN PATIENTS WITH LIVER CIRRHOSIS (CRISP-GV): A RANDOMIZED CONTROLLED TRIAL
- FIBROSIS IMPROVEMENT WITH PEGOZAFERMIN TREATMENT IN MASH PATIENTS WITH F4 FIBROSIS: ANALYSIS FROM A 24-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL (ENLIVEN)